The Radiopharmaceutics & PET Radiochemistry course will equip you with the skills to work as a radiopharmaceutical scientist in a PET radiochemistry centre (cyclotron unit) or in the field of conventional radiopharmacy, providing diagnostic and therapeutic radiopharmaceuticals to nuclear medicine centres and specialised commercial centres.
Highly specialist study pathway that is the first of its kind worldwide.
All learning materials are accessible online via King’s E-learning and Teaching Service (KEATS).
Opportunities to experience a working placement in a hospital, PET centre or industrial cyclotron centre.
Multidisciplinary study programme that attracts graduates from a range of science disciplines including chemists, bio-scientists, physicists, pharmacists.
Recognised by European Association of Nuclear Medicine, Masters students will be able to take the European Radiopharmacy exam.
On successful completion of the MSc students with a chemistry or pharmacy background can apply for membership with the Royal Society of Chemistry.
The Radiopharmaceutics & PET Radiochemistry course will provide you with opportunities to develop your knowledge, understanding and skills in the principles and practice of radiopharmaceutical science.
The course is made up of optional and required modules. The MSc pathway requires modules totalling 180 credits to complete the programme, 60 of which will come from a research project. You will complete the course in one year, from September to September.
Course format and assessment
We use lectures, tutorials and laboratory practicals to deliver most of the modules on the programme. You will also be expected to undertake a significant amount of independent study.
Each 30-credit module typically requires attendance at lectures/tutorials (80%) and labs (20%) for 24 full days. Each of these full days’ will include at least six hours of contact time.
Typically, one credit equates to 10 hours of work.
The course is assessed by a variety of mechanisms including:
Unseen written examinations
Practical laboratory work and reports
Case studies and oral presentations
Laboratory/ library-based research projects
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they may change if the course modules change.
This course is accredited by the European Association of Nuclear Medicine – EANM (Radiopharmacy Education Board) and the Royal Society of Chemistry – RSC.
Expected destinations are the NHS and commercial nuclear medicine services, the pharmaceutical industry or PhD research.